51 – 60 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Wnt5a Signals through DVL1 to Repress Ribosomal DNA Transcription by RNA Polymerase I
- Contribution to journal › Article
-
Mark
VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
- Contribution to journal › Article
-
Mark
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
- Contribution to journal › Article
-
Mark
Targeting tumour vasculature by inhibiting activin receptor-like kinase (ALK)1 function
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
- Contribution to journal › Article
-
Mark
Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling
- Contribution to journal › Article
-
Mark
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
- Contribution to journal › Article
- 2015
-
Mark
Gpr116 Receptor Regulates Distinctive Functions in Pneumocytes and Vascular Endothelium.
- Contribution to journal › Article
-
Mark
Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer.
- Contribution to journal › Article
